TruSight Cardio

TruSight Cardio

The TruSight Cardio Sequencing Kit is a comprehensive, cost-effective solution for identifying causal variants implicated in Inherited Cardiac Conditions (ICCs). The panel content is designed with expertly defined genes selected in collaboration with the Imperial College of London. 99% of the targeted regions are covered at a depth of at least 20x. The cost to sequence is ~$1 US per gene and is fully supported on Illumina industry-leading sequencing and informatics platforms.

Catalog ID(s):
FC-141-1010 TruSight Cardio Sequencing Kit for MiSeq and MiSeqDx (12 indexes, 12 samples, 1 enrichment)
FC-141-1011 TruSight Cardio Sequencing Kit for NextSeq (48 indexes, 48 samples, 4 enrichments)
Order Now Support

Please rotate your device for details

* Library prep is compatible with all Illumina instruments. Recommended instruments chosen based on typical output and analysis need for selected application.
† Based on 300x mean coverage of targeted content.
Project Recommendations
Species Compatibility Human
Recommended Illumina Instrument* MiSeq NextSeq 500
Run Mode - Mid Output
Recommended Samples per run† 12 (v2 chemistry) 48
Max Recommended Read Length 2x150 bp 2x150 bp
Recommended Secondary Analysis
  • MiSeq Reporter Enrichment Workflow
  • BWA Enrichment BaseSpace App
  • Isaac Enrichment v2 BaseSpace App
  • BWA Enrichment BaseSpace App
Recommended Down Stream Analysis VariantStudio VariantStudio
Order Now Support
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.